James Shin
Stock Analyst at Deutsche Bank
(3.13)
# 1,229
Out of 5,012 analysts
22
Total ratings
60%
Success rate
12.93%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintains: Buy | $1,010 → $900 | $843.63 | +6.68% | 5 | Aug 11, 2025 | |
| IMTX Immatics | Initiates: Buy | $10 | $9.41 | +6.27% | 1 | May 28, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $116.78 | +2.76% | 2 | Feb 18, 2025 | |
| MRK Merck & Co. | Downgrades: Hold | $128 → $105 | $87.61 | +19.85% | 2 | Feb 18, 2025 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $295.54 | +3.20% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $87.17 | -31.17% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $44.66 | +0.76% | 3 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $31.41 | +91.02% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $232.83 | -35.58% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $583.24 | +37.16% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.49 | +571.14% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.84 | +1,324.67% | 1 | Nov 9, 2023 |
Eli Lilly and Company
Aug 11, 2025
Maintains: Buy
Price Target: $1,010 → $900
Current: $843.63
Upside: +6.68%
Immatics
May 28, 2025
Initiates: Buy
Price Target: $10
Current: $9.41
Upside: +6.27%
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $116.78
Upside: +2.76%
Merck & Co.
Feb 18, 2025
Downgrades: Hold
Price Target: $128 → $105
Current: $87.61
Upside: +19.85%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $295.54
Upside: +3.20%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $87.17
Upside: -31.17%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $44.66
Upside: +0.76%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $31.41
Upside: +91.02%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $232.83
Upside: -35.58%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $583.24
Upside: +37.16%
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $1.49
Upside: +571.14%
Nov 9, 2023
Initiates: Buy
Price Target: $12
Current: $0.84
Upside: +1,324.67%